Grant, Call number PAR-25-374
Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)
National Institutes of Health
- , Add deadline: choose a calendar
- Institution applies
- Drug Repurposing, Bio-Informatics and
About
Investigators can assess whether approved or investigational medicines developed for other conditions could be repurposed for Alzheimer’s disease or related dementias. The grant also supports research on combinations predicted to affect disease mechanisms.
Topics
- Drug Repositioning, search World Wide
- Combination Therapy, search World Wide
- Alzheimer’s disease, search World Wide
- Related Dementias, search World Wide
- investigational medicines, search World Wide
- disease mechanisms, search World Wide
- Translational Bioinformatics, search World Wide
- Experimental Approaches, search World Wide
- R01, search World Wide
Eligibility
Covers: R01 support for preclinical research. Clinical trials are outside this call.
Eligible organizations based outside the US may apply.
Eligible organizations include universities, nonprofit research organizations and other categories specified in the announcement. Eligible organizations based outside the US may apply.
Source: simpler.grants.gov